[Form 4] Incyte Genomics Inc Insider Trading Activity
Sheila A. Denton, EVP & General Counsel of Incyte Corp (INCY), reported insider transactions dated 09/02/2025. She exercised an employee stock option to acquire 598 shares at an exercise price of $58.06 and simultaneously sold 598 shares at $84.97. The Form 4 shows beneficial ownership amounts of 33,798 and 33,200 shares following the reported transactions, and notes that 32,544 shares are issuable from previously reported restricted stock units and performance units that have not vested. The filing indicates the transaction was made pursuant to a written plan consistent with Rule 10b5-1 and was signed on 09/04/2025 by an attorney-in-fact.
Sheila A. Denton, EVP e General Counsel di Incyte Corp (INCY), ha segnalato operazioni di insider datate 02/09/2025. Ha esercitato un'opzione azionaria riservata ai dipendenti per acquisire 598 azioni a un prezzo di esercizio di $58,06 e contemporaneamente ha venduto 598 azioni a $84,97. Il Form 4 indica una partecipazione beneficiaria di 33.798 e 33.200 azioni dopo le operazioni riportate, e precisa che 32.544 azioni sono emettibili da unit脿 azionarie vincolate e unit脿 legate a performance gi脿 segnalate che non sono ancora maturate. Il deposito riporta che la transazione 猫 avvenuta ai sensi di un piano scritto conforme alla Rule 10b5-1 ed 猫 stato firmato il 04/09/2025 da un procuratore.
Sheila A. Denton, EVP y Consejera General de Incyte Corp (INCY), inform贸 transacciones de insiders con fecha 02/09/2025. Ejerci贸 una opci贸n sobre acciones para empleados para adquirir 598 acciones a un precio de ejercicio de $58.06 y simult谩neamente vendi贸 598 acciones a $84.97. El Form 4 muestra participaciones beneficiarias de 33.798 y 33.200 acciones tras las transacciones reportadas, y se帽ala que 32.544 acciones son emitibles a partir de unidades restringidas y unidades por desempe帽o previamente informadas que no han vencido. El formulario indica que la operaci贸n se realiz贸 conforme a un plan escrito consistente con la Rule 10b5-1 y fue firmado el 04/09/2025 por un apoderado.
Incyte Corp (INCY)鞚� EVP 瓴� 齑濌磩氩曤毂呾瀯鞛� Sheila A. Denton鞚� 2025-09-02鞛� 雮措秬鞛� 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟. 攴鸽厐電� 歆侅洂 鞀ろ啞鞓奠厴鞚� 頄夓偓頃橃棳 頄夓偓臧� $58.06鞐� 598欤茧ゼ 旆摑頃橁碃 霃欖嫓鞐� 598欤茧ゼ 欤茧嫻 $84.97鞐� 毵る弰頄堨姷雼堧嫟. Form 4鞐愲姅 鞚措矆 瓯半灅 頉� 鞙犾澋 氤挫湢 欤检嫕鞚� 33,798欤� 氚� 33,200欤茧 旮办灛霅橃柎 鞛堨溂氅�, 32,544欤茧姅 旮半炒霃勲悳 鞝滍暅欤� 氚� 靹标臣 雼渼鞐愳劀 鞎勳 氩犾姢韸�(vesting)霅橃 鞎婌潃 氚滍枆 鞓堨爼 欤检嫕鞛勳潉 氇呾嫓頃橁碃 鞛堨姷雼堧嫟. 鞁犼碃靹滌棎電� 頃措嫻 瓯半灅臧� Rule 10b5-1鞐� 攵�頃╉晿電� 靹滊┐ 瓿勴殟鞐� 霐半澕 鞚措（鞏挫瓿� 2025-09-04鞐� 雽�毽澑(Attorney-in-fact)鞚� 靹滊獏頄堨潓鞚� 響滌嫓霅橃柎 鞛堨姷雼堧嫟.
Sheila A. Denton, EVP et General Counsel d'Incyte Corp (INCY), a d茅clar茅 des op茅rations d'initi茅s dat茅es du 02/09/2025. Elle a exerc茅 une option sur actions r茅serv茅e aux employ茅s pour acqu茅rir 598 actions au prix d'exercice de 58,06 $ et a simultan茅ment vendu 598 actions 脿 84,97 $. Le Form 4 indique des d茅tentions b茅n茅ficiaires de 33 798 et 33 200 actions suite aux op茅rations d茅clar茅es, et pr茅cise que 32 544 actions sont attribuables 脿 des unit茅s d'actions restreintes et des unit茅s de performance d茅j脿 d茅clar茅es qui ne sont pas encore acquises. Le d茅p么t pr茅cise que la transaction a 茅t茅 r茅alis茅e en vertu d'un plan 茅crit conforme 脿 la Rule 10b5-1 et a 茅t茅 sign茅e le 04/09/2025 par un mandataire.
Sheila A. Denton, EVP & General Counsel von Incyte Corp (INCY), meldete Insider-Transaktionen vom 02.09.2025. Sie 眉bte eine Mitarbeiter-Aktienoption aus, um 598 Aktien zum Aus眉bungspreis von $58,06 zu erwerben, und verkaufte gleichzeitig 598 Aktien zu $84,97. Im Form 4 sind nach den gemeldeten Transaktionen beg眉nstigte Beteiligungsbetr盲ge von 33.798 und 33.200 Aktien angegeben. Zudem wird vermerkt, dass 32.544 Aktien aus zuvor gemeldeten Restricted Stock Units und Performance Units, die noch nicht vested sind, ausgegeben werden k枚nnen. Die Einreichung gibt an, dass die Transaktion gem盲脽 einem schriftlichen Plan im Einklang mit Rule 10b5-1 erfolgte und am 04.09.2025 von einem Bevollm盲chtigten unterzeichnet wurde.
- Transaction made under a 10b5-1 written plan, as indicated by the checked box, which documents pre-established trading terms
- Full disclosure of amounts and prices including exercise price ($58.06) and sale price ($84.97), enabling transparent investor review
- Explanation of unvested awards provided (32,544 shares issuable under restricted stock units and performance units), which clarifies future dilution
- Insider sale of 598 shares at $84.97 is reported, which reduces the reporting person鈥檚 liquid holdings
- Form shows sizable unvested awards (32,544 shares), representing potential dilution that investors may need to consider
Insights
TL;DR: Insider exercised options and sold the same number of shares under a 10b5-1 plan; transactions are routine and disclose holdings.
The reporting shows a simultaneous option exercise of 598 shares at $58.06 and a sale of 598 shares at $84.97 on 09/02/2025. The checkbox indicates the sale was executed pursuant to a written 10b5-1 plan, which typically limits opportunistic timing questions. Beneficial ownership after the entries is reported as 33,798 and 33,200 shares, and the footnote clarifies 32,544 shares remain issuable from unvested RSUs and performance units, which is material to total dilution and future ownership calculations.
TL;DR: Disclosure is complete and includes 10b5-1 plan indication and signature by attorney-in-fact.
The Form 4 includes the required details: transaction codes, prices, amounts, and a provided explanation of unvested awards. The inclusion of a 10b5-1 plan checkbox and a dated signature by an attorney-in-fact on 09/04/2025 supports procedural compliance. The vesting schedule note for the option award clarifies exercisability and long-term alignment with company compensation practices.
Sheila A. Denton, EVP e General Counsel di Incyte Corp (INCY), ha segnalato operazioni di insider datate 02/09/2025. Ha esercitato un'opzione azionaria riservata ai dipendenti per acquisire 598 azioni a un prezzo di esercizio di $58,06 e contemporaneamente ha venduto 598 azioni a $84,97. Il Form 4 indica una partecipazione beneficiaria di 33.798 e 33.200 azioni dopo le operazioni riportate, e precisa che 32.544 azioni sono emettibili da unit脿 azionarie vincolate e unit脿 legate a performance gi脿 segnalate che non sono ancora maturate. Il deposito riporta che la transazione 猫 avvenuta ai sensi di un piano scritto conforme alla Rule 10b5-1 ed 猫 stato firmato il 04/09/2025 da un procuratore.
Sheila A. Denton, EVP y Consejera General de Incyte Corp (INCY), inform贸 transacciones de insiders con fecha 02/09/2025. Ejerci贸 una opci贸n sobre acciones para empleados para adquirir 598 acciones a un precio de ejercicio de $58.06 y simult谩neamente vendi贸 598 acciones a $84.97. El Form 4 muestra participaciones beneficiarias de 33.798 y 33.200 acciones tras las transacciones reportadas, y se帽ala que 32.544 acciones son emitibles a partir de unidades restringidas y unidades por desempe帽o previamente informadas que no han vencido. El formulario indica que la operaci贸n se realiz贸 conforme a un plan escrito consistente con la Rule 10b5-1 y fue firmado el 04/09/2025 por un apoderado.
Incyte Corp (INCY)鞚� EVP 瓴� 齑濌磩氩曤毂呾瀯鞛� Sheila A. Denton鞚� 2025-09-02鞛� 雮措秬鞛� 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟. 攴鸽厐電� 歆侅洂 鞀ろ啞鞓奠厴鞚� 頄夓偓頃橃棳 頄夓偓臧� $58.06鞐� 598欤茧ゼ 旆摑頃橁碃 霃欖嫓鞐� 598欤茧ゼ 欤茧嫻 $84.97鞐� 毵る弰頄堨姷雼堧嫟. Form 4鞐愲姅 鞚措矆 瓯半灅 頉� 鞙犾澋 氤挫湢 欤检嫕鞚� 33,798欤� 氚� 33,200欤茧 旮办灛霅橃柎 鞛堨溂氅�, 32,544欤茧姅 旮半炒霃勲悳 鞝滍暅欤� 氚� 靹标臣 雼渼鞐愳劀 鞎勳 氩犾姢韸�(vesting)霅橃 鞎婌潃 氚滍枆 鞓堨爼 欤检嫕鞛勳潉 氇呾嫓頃橁碃 鞛堨姷雼堧嫟. 鞁犼碃靹滌棎電� 頃措嫻 瓯半灅臧� Rule 10b5-1鞐� 攵�頃╉晿電� 靹滊┐ 瓿勴殟鞐� 霐半澕 鞚措（鞏挫瓿� 2025-09-04鞐� 雽�毽澑(Attorney-in-fact)鞚� 靹滊獏頄堨潓鞚� 響滌嫓霅橃柎 鞛堨姷雼堧嫟.
Sheila A. Denton, EVP et General Counsel d'Incyte Corp (INCY), a d茅clar茅 des op茅rations d'initi茅s dat茅es du 02/09/2025. Elle a exerc茅 une option sur actions r茅serv茅e aux employ茅s pour acqu茅rir 598 actions au prix d'exercice de 58,06 $ et a simultan茅ment vendu 598 actions 脿 84,97 $. Le Form 4 indique des d茅tentions b茅n茅ficiaires de 33 798 et 33 200 actions suite aux op茅rations d茅clar茅es, et pr茅cise que 32 544 actions sont attribuables 脿 des unit茅s d'actions restreintes et des unit茅s de performance d茅j脿 d茅clar茅es qui ne sont pas encore acquises. Le d茅p么t pr茅cise que la transaction a 茅t茅 r茅alis茅e en vertu d'un plan 茅crit conforme 脿 la Rule 10b5-1 et a 茅t茅 sign茅e le 04/09/2025 par un mandataire.
Sheila A. Denton, EVP & General Counsel von Incyte Corp (INCY), meldete Insider-Transaktionen vom 02.09.2025. Sie 眉bte eine Mitarbeiter-Aktienoption aus, um 598 Aktien zum Aus眉bungspreis von $58,06 zu erwerben, und verkaufte gleichzeitig 598 Aktien zu $84,97. Im Form 4 sind nach den gemeldeten Transaktionen beg眉nstigte Beteiligungsbetr盲ge von 33.798 und 33.200 Aktien angegeben. Zudem wird vermerkt, dass 32.544 Aktien aus zuvor gemeldeten Restricted Stock Units und Performance Units, die noch nicht vested sind, ausgegeben werden k枚nnen. Die Einreichung gibt an, dass die Transaktion gem盲脽 einem schriftlichen Plan im Einklang mit Rule 10b5-1 erfolgte und am 04.09.2025 von einem Bevollm盲chtigten unterzeichnet wurde.
FAQ
What transactions did Sheila A. Denton report on Form 4 for INCY?
Was the sale by the Incyte insider part of a 10b5-1 trading plan?
How many shares does the reporting person beneficially own after the transactions?
Are there unvested awards disclosed in the Form 4 for INCY?
Who signed the Form 4 and when was it filed?
